Lung Abscess Located in Lesion of Lung Tumor and Multiple Cavities due to Pulmonary Tuberculosis: A Case Report
Downloads
Introduction: People with tuberculosis (TB) have an increased risk of pulmonary cancer. They are also disproportionately affected by risk factors like immune suppression, smoking, and alcohol misuse. A lung tumor is reported to have occurred after an episode of TB, but we reported a patient with a lung tumor with co-infection TB and lung abscess at the same time.
Case: A 73-year-old man was hospitalized at Arifin Achmad General Hospital, Pekanbaru, with a 3-day history of bloody cough 2-3 times a day, 1-2 tablespoons estimated by the patient for blood from the cough. The patient had a cough with white phlegm in the last 4 months before the bloody cough. The patient also had a fever, night sweats, a limp body, decreased appetite for 6 months, and decreased body weight by 15 kg in the last year. Heterogenic consolidation on the superior lobe of the lung with prominence compression and irregular boundaries in the apex was found. We found an air bronchogram and multiple cavities with air-fluid levels inside the lesion. We also found a satellite nodule in the inferior lung and a mass connected with the chest wall. GeneXpert showed low detection for Mycobacterium tuberculosis. The patient was diagnosed with a left lung abscess, pulmonary TB, left lung tumor T4N2M1a, unspecified type of tumor stage IVA PS2, and osteoporosis.
Conclusion: Lung tumors could also be diagnosed with co-infection TB. Proper diagnosis to make sure cancer and TB are co-infected is necessary. Therefore, it will not be just a single disease that is treated.
Penyakit DJP dan P. Pedoman Pengendalian Faktor Risiko Kanker Paru. Jakarta, 2018.
Parker CS, Siracuse CG, Litle VR. Identifying Lung Cancer in Patients with Active Pulmonary Tuberculosis. J Thorac Dis (Medical Surg Manag Pulm Infect; 10, https://jtd.amegroups.com/article/view/22911 (2018).
Isbaniah F, Burhan E, Sinaga BYM, et al. Tuberkulosis: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. 2nd ed. Jakarta: Perhimpunan Dokter Paru Indonesia (PDPI), https://bukupdpi.klikpdpi.com/wp-content/uploads/2022/08/BUKU-GUIDELINE-TB-2021.pdf (2021).
(WHO) WHO. Global Tuberculosis Report 2021. Geneva, https://www.who.int/publications-detail-redirect/9789240037021 (2021).
(WHO) WHO. Global Tuberculosis Report 2022. Geneva, https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 (2022).
Luczynski P, Poulin P, Romanowski K, et al. Tuberculosis and Risk of Cancer: A Systematic Review and Meta-Analysis. PLoS One 2022; 17: e0278661. [PubMed]
Cabrera-Sanchez J, Cuba V, Vega V, et al. Lung Cancer Occurrence after an Episode of Tuberculosis: A Systematic Review and Meta-Analysis. Eur Respir Rev 2022; 31: 220025. [PubMed]
Ho L-J, Yang H-Y, Chung C-H, et al. Increased Risk of Secondary Lung Cancer in Patients with Tuberculosis: A Nationwide, Population-Based Cohort Study. PLoS One 2021; 16: e0250531. [PubMed]
Oh C-M, Roh Y-H, Lim D, et al. Pulmonary Tuberculosis is Associated with Elevated Risk of Lung Cancer in Korea: The Nationwide Cohort Study. J Cancer 2020; 11: 1899–1906. [PubMed]
Stella GM, Kolling S, Benvenuti S, et al. Lung-Seeking Metastases. Cancers; 11. Epub ahead of print 2019. [PubMed]
Chai M, Shi Q. The Effect of Anti-Cancer and Anti-Tuberculosis Treatments in Lung Cancer Patients with Active Tuberculosis: A Retrospective Analysis. BMC Cancer 2020; 20: 1121. [PubMed]
Tan KT, Kannan SK, Rajahram GS. A Case of Pulmonary Tuberculosis Masquerading as Lung Carcinoma. Med J Malaysia 2019; 74: 547–548. [PubMed]
Shu C-C, Chang S-C, Lai Y-C, et al. Factors for the Early Revision of Misdiagnosed Tuberculosis to Lung Cancer: A Multicenter Study in A Tuberculosis-Prevalent Area. J Clin Med; 8. Epub ahead of print May 2019. [PubMed]
Preda M, Tănase BC, Zob DL, et al. The Bidirectional Relationship between Pulmonary Tuberculosis and Lung Cancer. International Journal of Environmental Research and Public Health; 20. Epub ahead of print 2023. [PubMed]
Qin Y, Chen Y, Chen J, et al. The Relationship between Previous Pulmonary Tuberculosis and Risk of Lung Cancer in the Future. Infect Agent Cancer 2022; 17: 20. [PubMed]
Chen G-L, Guo L, Yang S, et al. Cancer Risk in Tuberculosis Patients in a High Endemic Area. BMC Cancer 2021; 21: 679. [PubMed]
Molina-Romero C, Arrieta O, Hernández-Pando R. Tuberculosis and Lung Cancer. Salud Publica Mex 2019; 61: 286–291. [PubMed]
Mashrabovna II, Faxriddinovna ND. Modern Method of Differential Diagnosis Tuberculosis and Lung Cancer. Sci J Res Med 2022; 1: 21–30. [Journal]
Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. International Journal of Molecular Sciences; 22. Epub ahead of print 2021. [PubMed]
Sun W, Zhang L, Liang J, et al. Comparison of Clinical and Imaging Features between Pulmonary Tuberculosis Complicated with Lung Cancer and Simple Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis. Epidemiol Infect 2022; 150: e43. [PubMed]
Petrilli JD, Araújo LE, da Silva LS, et al. Whole Blood mRNA Expression-Based Targets to Discriminate Active Tuberculosis from Latent Infection and Other Pulmonary Diseases. Sci Rep 2020; 10: 22072. [PubMed]
Xiang Y, Huang C, He Y, et al. Cancer or Tuberculosis: A Comprehensive Review of the Clinical and Imaging Features in Diagnosis of the Confusing Mass. Front Oncol 2021; 11: 644150. [PubMed]
Wei S, Shi B, Zhang J, et al. Differentiating Mass-Like Tuberculosis from Lung Cancer Based on Radiomics and CT Features. Transl Cancer Res 2021; 10: 4454–4463. [PubMed]
Copyright (c) 2024 Sri Indah Indriani, Elvando Tunggul Mauliate Simatupang, Adelia Pratiwi, Adityo Wibowo, Andreas Makmur, Wiwit Ade Fidiawati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.